Product Information
DOXAZOSIN MESYLATE 2 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.0656 per EA under NDC 00904552361. Its NADAC has been published 492 times since Mar 1, 2017.
FDA first approved this application on Oct 18, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Doxazosin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904552361
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA075580FDA Approved
10/18/2000
TE Code
AB
On Market Since
7/14/2011
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 2 MG TAB has been published 492 times since Mar 1, 2017, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.3349 (Apr 12, 2017) |
| All-time low | $0.0562 (Nov 20, 2024) |
| 52-week high | $0.0716 |
| 52-week low | $0.0656 |
| Median price | $0.0816 |
| Average price | $0.1306 |
| Largest weekly change | -28.9% (Jul 22, 2020) |
| Weeks tracked | 492 |
| Tracking since | Mar 1, 2017 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 2 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 2 MG TAB, manufactured by Major Pharmaceuticals, is $0.0656 per EA (NDC 00904552361), effective Aug 19, 2026.
How has the price of DOXAZOSIN MESYLATE 2 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 2 MG TAB has declined 79.2%. It has been tracked across 492 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 2 MG TAB?
Since Mar 1, 2017, the NADAC for DOXAZOSIN MESYLATE 2 MG TAB has ranged from a low of $0.0562 (Nov 20, 2024) to a high of $0.3349 (Apr 12, 2017), with a median of $0.0816 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 2 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXAZOSIN MESYLATE 2 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXAZOSIN MESYLATE 2 MG TAB?
DOXAZOSIN MESYLATE 2 MG TAB (NDC 00904552361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.